Project Grant 2227727
- This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award, under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $275,000 to Envision Health Technologies Inc. to develop a novel adaptive perimetry software solution for the early detection and monitoring of vision loss due to glaucoma. The project aims to create a fully automated adaptive perimetry test that combines the standardization of static automated perimetry (SAP)...
- Federal Project Grant Award Summary Eye C Better Corp received a $315,825 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025 through August 31, 2026. The award funds development of a novel, non-invasive intraocular pressure (IOP) measurement technology called Photonic IOP Biomonitoring (PIB) designed to address glaucoma management challenges. Glaucoma affects over 5 million Americans and costs the U.S. economy...
- Under this $375,940 Phase I Small Business Innovation Research (SBIR) award from the National Eye Institute's Vision Research program (CFDA 93.867), Neurofieldz Inc. is developing and validating the NeuroVEP system, a portable wireless diagnostic device for objective assessment of optic neuropathies and other diseases affecting the afferent visual system. The NeuroVEP system utilizes electric field encephalography to measure visual evoked potentials (VEP) at the visual cortex in response to...
- This $976,308 National Science Foundation project grant funds the University of Miami to develop a novel fundus multiwavelength imaging device for simultaneous multiwavelength imaging of the retinal nerve fiber layer. The goal is to design, construct, and validate a non-contact optical method that can sensitively detect early glaucoma damage through in vivo measurement of retinal spectral reflectance changes. Specifically, the University of Miami will design and construct a new fundus imaging...
- The National Science Foundation awarded 123 See, Inc. a $276,000 Small Business Innovation Research Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant supports the development of a vision care station for on-demand rapid examination of visual performance. The station will allow for quick evaluation of vision without an extensive appointment. The 15-month project period runs from December 2021 through February 2023. The NSF Technology,...
- This $1,000,000 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) will support the development of a gaze-independent, contactless autorefractor technology for use in a self-serve, autonomous vision exam kiosk. The project aims to improve access to vision care and eyeglasses for Americans by providing a rapid, convenient vision assessment solution that can be deployed in retail stores and public spaces. Key...
- This $599,056 Project Grant, awarded by the National Science Foundation (NSF) Division of Civil, Mechanical, and Manufacturing Innovation under the Engineering program (CFDA 47.041), supports a three-year research initiative (October 1, 2025 – September 30, 2028) at the University of Michigan-Dearborn to advance understanding of aqueous fluid flow biomechanics in the human eye. The project will deliver quantitative research findings and computational models characterizing velocity profiles,...
- Grant Award Summary The National Eye Institute's Vision Research program (CFDA 93.867) awarded The Aird a $610,000 Project Grant effective September 1, 2025, through August 31, 2026, to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system for high-resolution retinal imaging in rodent models. The primary deliverable is a portable, commercialized AO-OCT imaging system featuring a customized contact lens interface capable of capturing wide-field (150-degree)...
- Federal Project Grant Award Summary Kineolabs, Inc. received a $300,001 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography imaging system (LS-SS-OCT). The system is designed for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The one-year project, which commenced July 1, 2025 and concludes June...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded University of California, Irvine $179,964 under the Vision Research program (CFDA 93.867) on March 1, 2025, for a project grant extending through July 10, 2029. The project focuses on developing deep learning-based biomarkers for optic neuropathies using retinal Optical Coherence Tomography (OCT) imaging analysis. The research will employ advanced computational techniques, including deep generative models, neural field image...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including primary care physicians and emergency doctors, to more closely monitor patients presenting with sudden vision changes or headaches without needing additional expensive tests only available at specialized clinics. It could also help predict patient responses to treatment and disease progression. If validated, this technology has the potential to increase physician productivity through remote eye exams at shorter intervals and help triage patients more effectively. The award period is July 1, 2022 through June 30, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $50.0k | 6/17/22 |